Gene · 22941
Papers1,856
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,856
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Paracentric inversion disrupting the SHANK2 gene. | Eur J Med Genet | 2025 | 40057302 | PubTator, text mining | PubMed |
| Detection of Novel hub-methylated differentially expressed genes in pregnant women with gestational diabetes mellitus via WGCNA of epigenome-wide and transcriptome-wide profiling. | Int J Health Sci (Qassim) | 2025 | 40046791 | PubTator, text mining | PubMed |
| Overexpression of SHANK2 contributes malignant outcomes as a Hippo pathway regulator in gastric cancer. | Am J Cancer Res | 2025 | 39949934 | PubTator, text mining | PubMed |
| MSC-exosomes pretreated by Danshensu extracts pretreating to target the hsa-miR-27a-5p and STAT3-SHANK2 to enhanced antifibrotic therapy. | Stem Cell Res Ther | 2025 | 39901236 | PubTator, text mining | PubMed |
| Linear ubiquitination at damaged lysosomes induces local NFKB activation and controls cell survival. | Autophagy | 2025 | 39744815 | PubTator, text mining | PubMed |
| Chronic Catatonia in an Individual With a De Novo Missense SHANK1 Variant. | Am J Med Genet A | 2025 | 39569511 | PubTator, text mining | PubMed |
| Multi-Omics Approach Reveals Genes and Pathways Affected in Miller-Dieker Syndrome. | Mol Neurobiol | 2025 | 39508990 | PubTator, text mining | PubMed |
| Expanding the clinical phenotype of SHANK2-related disorders: childhood apraxia of speech in a patient with a novel SHANK2 pathogenic variant. | Eur Child Adolesc Psychiatry | 2025 | 38700702 | PubTator, text mining | PubMed |
| SHANK2-AS3: A potential biomarker for Parkinson's disease and its role in neuronal apoptosis via NF-κB signaling in SH-SY5Y cells. | Heliyon | 2024 | 39553632 | PubTator, text mining | PubMed |
| Key Synaptic Pathology in Autism Spectrum Disorder: Genetic Mechanisms and Recent Advances. | J Integr Neurosci | 2024 | 39473158 | PubTator, text mining | PubMed |
| Gene-expression profile analysis to disclose diagnostics and therapeutics biomarkers for thyroid carcinoma. | Comput Biol Chem | 2024 | 39454454 | PubTator, text mining | PubMed |
| Animal Models of Autistic-like Behavior in Rodents: A Scoping Review and Call for a Comprehensive Scoring System. | Int J Mol Sci | 2024 | 39408797 | PubTator, text mining | PubMed |
| Elevated SH3 and Multiple Ankyrin Repeat Domains 2 Expression Correlates With Improved Glioma Prognosis. | Int J Genomics | 2024 | 39397895 | PubTator, text mining | PubMed |
| Correction to: Simulated complexes formed from a set of postsynaptic proteins suggest a localised effect of a hypomorphic Shank mutation. | BMC Neurosci | 2024 | 39385071 | PubTator, text mining | PubMed |
| Reliability of motion phase identification for long-track speed skating using inertial measurement units. | PeerJ | 2024 | 39351374 | PubTator, text mining | PubMed |
| Buyang huanwu decoction improves synaptic plasticity of ischemic stroke by regulating the cAMP/PKA/CREB pathway. | J Ethnopharmacol | 2024 | 39089658 | PubTator, text mining | PubMed |
| Correction: Differentially altered social dominance- and cooperative-like behaviors in Shank2- and Shank3-mutant mice. | Mol Autism | 2024 | 39080803 | PubTator, text mining | PubMed |
| Leveraging FAM features to predict the prognosis of LGG patients and immunotherapy outcome. | Am J Cancer Res | 2024 | 39005680 | PubTator, text mining | PubMed |
| Simulated complexes formed from a set of postsynaptic proteins suggest a localised effect of a hypomorphic Shank mutation. | BMC Neurosci | 2024 | 38971749 | PubTator, text mining | PubMed |
| Synapse and primary cilia dysfunctions in Autism Spectrum Disorders. Avenues to normalize these functions. | Rev Neurol (Paris) | 2024 | 38925998 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/22941/papers?page=3